Welcome to the investors section of Adocia  

Adocia is a biotechnology company specialized in the development of best-in-class medicines from already approved therapeutic proteins.


Latest Press Releases
2018/07/25Half year report on Adocia’s liquidity agreement with Kepler Capital Markets
Read more
2018/07/18Adocia Presents First Half 2018 Financial Results
Read more

All Press releases

Next events

1-5 October 2018 EASD, Berlin, Germany - 54th Annual Meeting of the European Association for the Study of Diabetes
See event

All events